G1 Therapeutics, Inc. (GTHX) Tops Q1 EPS by 11c

G1 Therapeutics, Inc. (NASDAQ: GTHX) reported Q1 EPS of ($0.53), $0.11 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $12.95 million versus the consensus estimate of $11.17 million.

For earnings history and earnings-related data on G1 Therapeutics, Inc. (GTHX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand
• BMO starts chip stocks coverage: Here are its preferred picks